Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation
Completed clinical trial investigating posttransplant diabetes mellitus and associated left ventricular hypertrophy and arterial stiffness i…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients [NA]
This completed clinical trial from Wayne State University studied pre-clinical cardiac dysfunction in asymptomatic hypertensive patients. Re…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Effects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in Hemodialysis Patients [Phase 4]
A Phase 4 clinical trial evaluated whether volume control guided by a body composition monitor improves blood pressure and cardiac condition…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168) [Phase 3]
Phase 3 trial assessing whether statin therapy can reduce left ventricular hypertrophy in hypertensive patients; the study MK0653A-168 was t…
-
CLINICAL_TRIALS research · 2013-07-22Clinical Trial Update: Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]
A Phase 4 clinical trial is evaluating the combination of eplerenone and aliskiren in hypertensive patients with left ventricular hypertroph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for losartan potassium by Alembic Pharmaceuticals Limited.
-
FDA approval · 2013-01-28FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited (ANDA202230), authorizing the generic p…
-
FDA approval · 2012-12-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, resulting in approval of a generic losartan po…
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for Losartan Potassium 25 mg by Strides Pharma Science Limited, authorizing the generic product fo…
-
CLINICAL_TRIALS research · 2012-08-16Clinical Trial Update: Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression [NA]
A completed study update examining the pathophysiological mechanisms of hypertensive left ventricular hypertrophy and strategies to optimize…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy [NA]
ClinicalTrials.gov update indicates a terminated study assessing the effect of heart rate on cardiac index in patients with left ventricular…
-
FDA approval · 2012-07-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for losartan potassium submitted by Quallent Pharmaceuticals Health LLC under ANDA078243.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) [Phase 4]
Phase 4 clinical trial update for candesartan investigating effectiveness in patients with hypertension and left ventricular hypertrophy; th…
-
FDA approval · 2012-01-03FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for losartan potassium from Quallent Pharmaceuticals Health LLC for an existing generic product.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 [Phase 3]
The update reports the Phase 3 PRIMO trial evaluating paricalcitol capsules for renal failure–associated cardiac morbidity in CKD stages 3/4…
-
CLINICAL_TRIALS trial_result · 2011-11-29Clinical Trial Update: Value of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Cardiomyopathy
A completed clinical trial evaluating cardiac magnetic resonance–derived parameters for diagnosing left ventricular noncompaction cardiomyop…
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients [NA]
A completed clinical trial evaluating the effects of lowering dialysate sodium in hypertensive patients undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension [NA]
This update concerns a clinical trial evaluating regional myocardial dynamics at physical stress in essential hypertension with left ventric…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]
Phase 4 clinical trial assessing the effect of valsartan on left ventricular function in patients with hypertension and left ventricular hyp…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy [Phase 2, Phase 3]
This ClinicalTrials.gov entry reports a Phase 2/3 trial evaluating perhexiline for myocardial protection in left ventricular hypertrophy, wi…
-
CLINICAL_TRIALS research · 2011-07-28Clinical Trial Update: Viennese Prevalence Study of Anderson-Fabry Disease
This entry reports an ongoing clinical trial conducted by the Medical University of Vienna to study the prevalence of Fabry disease, includi…
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
Clinical trial update examining serum sclerostin levels, cardiovascular parameters, and carpal tunnel syndrome in maintenance hemodialysis p…
-
FDA approval · 2011-06-10FDA Approved: COZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2011-06-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Solco Healthcare US, LLC)
The FDA approved Losartan Potassium as a generic product from Solco Healthcare US, LLC under original ANDA 091497.
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy [Phase 4]
This update summarizes a Phase 4 trial evaluating irbesartan in hypertensive patients with left ventricular hypertrophy, sponsored by Sanofi…